Subscribe
Magazine
Past Issues
Surveys
Industry Statistics
About Us
Members Only
Best Places to Work
General Interest
Exploration & Development
Drilling & Production
Refining & Processing
Pipelines & Transportation
LNG
Energy Transition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
PennEnergy Stock Watch
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
< Previous
1
2
3
4
5
6
Next >
Health-care system Sesame to offer compounded versions of Wegovy through new $249 weight loss program
August 21, 2024
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Technology
From
CNBC.com News
Eli Lilly's weight loss drug slashes the risk of developing diabetes in long-term trial
August 20, 2024
Tags
Health & Science
Breaking News: Business
Business News
From
CNBC.com News
What's next for the Biden administration's Medicare drug price negotiations
August 15, 2024
Tags
Health & Science
Business News
Breaking News: Politics
From
CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
August 15, 2024
Tags
Amgen Inc
Merck & Co Inc
Bristol/Myers Squibb Co
From
CNBC.com News
Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
August 14, 2024
Tags
Eli Lilly and Co
Health care industry
Healthy Returns
From
CNBC.com News
Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs
August 13, 2024
Tags
Breaking news
Pharmaceuticals
Business
From
CNBC.com News
Eli Lilly's Zepbound and Mounjaro now available in U.S. after shortages, FDA says
August 02, 2024
Tags
Companies
US: News
Biotechnology
From
CNBC.com News
Eli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage study
August 01, 2024
Tags
Business
Pharmaceuticals
Science
From
CNBC.com News
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
July 31, 2024
Tags
Augmedix Inc
Health & Science
Novo Nordisk A/S
From
CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
July 30, 2024
Tags
Business News
Breaking News: Business
Health & Science
From
CNBC.com News
Swiss pharma giant Roche to accelerate Wegovy rival drugs after positive trial data
July 29, 2024
Tags
Roche Holding AG
Eli Lilly and Co
Business
From
CNBC.com News
Viking Therapeutics stock jumps 16% after drugmaker moves weight loss injection to late-stage trial
July 25, 2024
Tags
Viking Therapeutics Inc
Health care industry
Eli Lilly and Co
From
CNBC.com News
Wegovy rival to be part of a suite of weight loss drugs, Roche CEO says following positive trial results
July 25, 2024
Tags
Biotechnology
Pharmaceuticals
Biotech and Pharmaceuticals
From
CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
July 23, 2024
Tags
Novartis AG
Health care industry
Johnson & Johnson
From
CNBC.com News
Novo Nordisk's Wegovy weight loss drug wins UK approval for use as a heart treatment
July 23, 2024
Tags
Pharmaceuticals
Health & Science
Biotech and Pharmaceuticals
From
CNBC.com News
Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche
July 17, 2024
Tags
Eli Lilly and Co
Zealand Pharma A/S
Pharmaceuticals
From
CNBC.com News
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
July 16, 2024
Tags
Novo Nordisk A/S
Pfizer Inc
Merck & Co Inc
From
CNBC.com News
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
July 11, 2024
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Health & Science
From
CNBC.com News
Pfizer moves forward with once-daily version of weight loss pill after setbacks
July 11, 2024
Tags
Health care industry
Eli Lilly and Co
Novo Nordisk A/S
From
CNBC.com News
Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'
July 10, 2024
Tags
Novo Nordisk A/S
Stock Picks
Investment strategy
From
CNBC.com News
FTC to sue drug middlemen over prices of medications including insulin
July 10, 2024
Tags
Politics
Biotech and Pharmaceuticals
Novo Nordisk A/S
From
CNBC.com News
CNBC Daily Open: French left-wing shock victory, Boeing guilty plea
July 08, 2024
Tickers
LAWS
Tags
Streaming media technology
Breaking News: Markets
Stock markets
From
CNBC.com News
CNBC Daily Open: French far-right advance blocked
July 07, 2024
Tags
Daily Open
Cryptocurrency
Bitcoin
From
CNBC.com News
This ETF is trying to satisfy appetites for weight loss stocks
July 06, 2024
Tags
Exchange/traded funds
Diabetes
Eli Lilly and Co
From
CNBC.com News
Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition
July 04, 2024
Tags
Health care industry
Science
Pharmaceuticals
From
CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
July 03, 2024
Tags
Technology
Cigna Corp
Oracle Corp
From
CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
June 26, 2024
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Zealand Pharma A/S
From
CNBC.com News
5 things to know before the stock market opens
June 25, 2024
Tags
Politics
NVIDIA Corp
Markets
From
CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
June 25, 2024
Tags
US Top News and Analysis
Europe: Top News And Analysis
Europe News
From
CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
June 24, 2024
Tags
Pharmaceuticals
Business
Companies
From
CNBC.com News
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.